Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 52, 2018, Pages E12323-E12332

  Luo, Guo ^a   Ambati, Aditya ^a   Lin, Ling ^a   Bonvalet, Mélodie ^a   Partinen, Markku ^b,c   Ji, Xuhuai ^a   Maecker, Holden Terry ^a   Mignot, Emmanuel Jean Marie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Vitalmed Research Centre   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoimmunity; DQ0602; Narcolepsy; TCR; Tetramer

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA DQ ANTIGEN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; OREXIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TETRAMER; VIRUS NUCLEOPROTEIN; AUTOANTIGEN; HCRT PROTEIN, HUMAN; HEMAGGLUTININ; HLA-DQB1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; SIGNAL PEPTIDE;

ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA A (H1N1); MOLECULAR MIMICRY; NARCOLEPSY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TYPE 1 NARCOLEPSY; ADOLESCENT; ADULT; CHILD; FEMALE; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); MALE; METABOLISM; MIDDLE AGED; PATHOGENICITY; VACCINATION;

ADOLESCENT; ADULT; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CHILD; EPITOPES; FEMALE; HEMAGGLUTININS; HLA-DQ BETA-CHAINS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOLECULAR MIMICRY; NARCOLEPSY; OREXINS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; VACCINATION;

EID: 85059216951     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1818150116     Document Type: Article

References (59)

1. Han F, et al. (2013) Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet 9:e1003880.
2. Faraco J, et al. (2013) ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 9:e1003270.
3. Kornum BR, et al. (2011) Common variants in P2RY11 are associated with narcolepsy. Nat Genet 43:66–71.
4. Hor H, et al. (2010) Genome-wide association study identifies new HLA class II hap-lotypes strongly protective against narcolepsy. Nat Genet 42:786–789, and erratum (2011) 43:388.
5. Hallmayer J, et al. (2009) Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41:708–711, and erratum (2009) 41:859.
6. Ollila HM, et al. (2015) HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 96:136–146, and erratum (2015) 96:852.
7. Martinez-Orozco FJ, Vicario JL, De Andres C, Fernandez-Arquero M, Peraita-Adrados R (2016) Comorbidity of narcolepsy type 1 with autoimmune diseases and other immunopathological disorders: A case-control study. J Clin Med Res 8:495–505.
8. Singh AK, Mahlios J, Mignot E (2013) Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 43:26–31.
9. Aran A, et al. (2009) Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32:979–983.
10. Han F, et al. (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70:410–417.
11. Dye TJ, Gurbani N, Simakajornboon N (2018) Epidemiology and pathophysiology of childhood narcolepsy. Paediatr Respir Rev 25:14–18.
12. Feltelius N, et al. (2015) A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden. J Intern Med 278:335–353.
13. Ambati A, et al. (2015) Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases. J Intern Med 278:264–276.
14. Vaarala O, et al. (2014) Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: Implications for Pandemrix-associated narcolepsy risk. PLoS One 9:e114361.
15. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39–40.
16. Peyron C, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6: 991–997.
17. Thannickal TC, et al. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474.
18. De la Herrán-Arita AK, et al. (2013) CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med 5:216ra176.
19. + T-cells targeting HLA-DQA1*01:02/DQB1*06:02 restricted hypocretin/orexin epitopes in narcolepsy type 1 when detected by EliSpot. J Neuroimmunol 309:7–11.
20. Ramberger M, et al. (2017) CD4+ T-cell reactivity to orexin/hypocretin in patients with narcolepsy type 1. Sleep (Basel) 40:zsw070.
21. Tanaka S, Honda Y, Inoue Y, Honda M (2006) Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: Anti-Hcrt system antibody in narcolepsy. Sleep 29:633–638.
22. Cvetkovic-Lopes V, et al. (2010) Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 120:713–719.
23. Lind A, et al. (2014) A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010. J Autoimmun 50:99–106.
24. Ahmed SS, et al. (2015) Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 7:294ra105.
25. Giannoccaro MP, et al. (2017) Antibodies against hypocretin receptor 2 are rare in narcolepsy. Sleep (Basel) 40.
26. Luo G, et al. (2017) Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases. PLoS One 12:e0187305.
27. van der Heide A, Hegeman-Kleinn IM, Peeters E, Lammers GJ, Fronczek R (2015) Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination. J Neuroimmunol 283:58–62.
28. Ollila H, et al. (2018) Narcolepsy risk loci are enriched in immune cells and suggest autoimmune modulation of the T cell receptor repertoire. bioRxiv, 10.1101/373555. Preprint, posted July 22, 2018.
29. Bernard-Valnet R, et al. (2016) CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci USA 113:10956–10961.
30. Longstreth WT, Jr, Ton TG, Koepsell TD (2009) Narcolepsy and streptococcal infections. Sleep 32:1548.
31. Han F, Lin L, Li J, Dong XS, Mignot E (2013) Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 73:560.
32. Wu H, et al. (2014) Symptoms and occurrences of narcolepsy: A retrospective study of 162 patients during a 10-year period in eastern China. Sleep Med 15:607–613.
33. Weibel D, et al. (2018) Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines—Multi-country assessment. Vaccine 36:6202–6211.
34. Sarkanen T, Alakuijala A, Julkunen I, Partinen M (2018) Narcolepsy associated with Pandemrix vaccine. Curr Neurol Neurosci Rep 18:43.
35. Jacob L, et al. (2015) Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 47:44–57.
36. Han F, et al. (2012) HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 80:328–335.
37. Miyagawa T, et al. (2015) New susceptibility variants to narcolepsy identified in HLA class II region. Hum Mol Genet 24:891–898.
38. Mignot E, et al. (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68:686–699.
39. Tafti M, et al. (2014) DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep (Basel) 37:19–25.
40. Bedford T, Cobey S, Beerli P, Pascual M (2010) Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS Pathog 6:e1000918.
41. De la Herran-Arita AK, et al. (2014) Retraction of the research article: “CD4(+) T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy”. Sci Transl Med 6:247rt241.
42. Latorre D, et al. (2018) T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562:63–68.
43. Nicolson C, et al. (2012) An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine 30:745–751.
44. Demachi-Okamura A, et al. (2008) Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells. Cancer Sci 99: 1633–1642.
45. Dalal J, et al. (2013) Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev 27:565–578.
46. Kim Y, et al. (2012) Immune epitope database analysis resource. Nucleic Acids Res 40: W525–W530.
47. Glanville J, et al. (2017) Identifying specificity groups in the T cell receptor repertoire. Nature 547:94–98.
48. Sharon E, et al. (2016) Genetic variation in MHC proteins is associated with T cell receptor expression biases. Nat Genet 48:995–1002.
49. Sakurai T, et al. (1998) Orexins and orexin receptors: A family of hypothalamic neu-ropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573–585.
50. Zougman A, et al. (2008) Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res 7:386–399.
51. Dendrou CA, Petersen J, Rossjohn J, Fugger L (2018) HLA variation and disease. Nat Rev Immunol 18:325–339.
52. Raposo B, et al. (2018) T cells specific for post-translational modifications escape in-trathymic tolerance induction. Nat Commun 9:353.
53. Risnes LF, et al. (2018) Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest 128:2642–2650.
54. Han F, et al. (2014) HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep (Basel) 37:1601–1608.
55. Cushing A, et al. (2015) Emergence of hemagglutinin mutations during the course of influenza infection. Sci Rep 5:16178.
56. Montplaisir J, et al. (2014) Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 9:e108489.
57. La Gruta NL, Gras S, Daley SR, Thomas PG, Rossjohn J (2018) Understanding the drivers of MHC restriction of T cell receptors. Nat Rev Immunol 18:467–478.
58. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW (2005) Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 6:490–496.
59. Riley TP, et al. (2018) T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability. Nat Chem Biol 14:934–942.